Vertex Pharmaceuticals Stock Price History

VRTX Stock  USD 396.55  3.68  0.92%   
Below is the normalized historical share price chart for Vertex Pharmaceuticals extending back to July 24, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vertex Pharmaceuticals stands at 396.55, as last reported on the 13th of April 2024, with the highest price reaching 400.14 and the lowest price hitting 393.76 during the day.
IPO Date
24th of July 1991
200 Day MA
380.7376
50 Day MA
417.4556
Beta
0.368
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Vertex Stock, it is important to understand the factors that can impact its price. Vertex Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.12, which indicates the firm had a -0.12% return per unit of risk over the last 3 months. Vertex Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vertex Pharmaceuticals' Risk Adjusted Performance of (0.03), coefficient of variation of (1,934), and Variance of 1.47 to confirm the risk estimate we provide.
  
At this time, Vertex Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 23.9 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 153.1 M in 2024. . At this time, Vertex Pharmaceuticals' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 7.46 in 2024, whereas Price To Sales Ratio is likely to drop 10.12 in 2024. Vertex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1239

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsVRTX

Estimated Market Risk

 1.22
  actual daily
10
90% of assets are more volatile

Expected Return

 -0.15
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.12
  actual daily
0
Most of other assets perform better
Based on monthly moving average Vertex Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vertex Pharmaceuticals by adding Vertex Pharmaceuticals to a well-diversified portfolio.
Price Book
5.885
Enterprise Value Ebitda
20.2054
Price Sales
10.4814
Shares Float
257.6 M
Wall Street Target Price
464.98

Vertex Pharmaceuticals Stock Price History Chart

There are several ways to analyze Vertex Stock price data. The simplest method is using a basic Vertex candlestick price chart, which shows Vertex Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 30, 2024446.08
Lowest PriceApril 12, 2024396.55

Vertex Pharmaceuticals April 13, 2024 Stock Price Synopsis

Various analyses of Vertex Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Vertex Stock. It can be used to describe the percentage change in the price of Vertex Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Vertex Stock.
Vertex Pharmaceuticals Price Rate Of Daily Change 0.99 
Vertex Pharmaceuticals Price Action Indicator(2.24)
Vertex Pharmaceuticals Accumulation Distribution 18,571 
Vertex Pharmaceuticals Price Daily Balance Of Power(0.58)

Vertex Pharmaceuticals April 13, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Vertex Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Vertex Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in Vertex Stock and then apply it to test your longer-term investment strategies against Vertex.

Vertex Stock Price History Data

The price series of Vertex Pharmaceuticals for the period between Sun, Jan 14, 2024 and Sat, Apr 13, 2024 has a statistical range of 48.5 with a coefficient of variation of 2.51. The daily prices for the period are distributed with arithmetic mean of 421.04. The median price for the last 90 days is 420.48. The company experienced 2:1 stock split on 24th of August 2000.
OpenHighLowCloseVolume
04/12/2024 396.57  400.14  393.76  396.55  1,164,746 
04/11/2024 404.30  404.69  398.85  400.23  1,060,233 
04/10/2024 399.89  401.00  394.84  397.58  1,012,069 
04/09/2024 406.00  406.45  399.30  404.48  721,018 
04/08/2024 403.45  404.60  399.00  404.22  745,908 
04/05/2024 404.29  409.93  400.83  406.67  695,660 
04/04/2024 412.64  412.64  403.15  404.01  957,186 
04/03/2024 409.45  414.96  408.25  408.81  728,589 
04/02/2024 419.00  420.87  406.73  409.42  974,479 
04/01/2024 420.43  421.45  414.74  420.48  767,528 
03/28/2024 419.48  420.67  415.06  418.01  1,053,576 
03/27/2024 420.30  420.42  412.65  417.32  905,394 
03/26/2024 417.38  419.40  414.86  418.46  952,065 
03/25/2024 415.66  418.24  414.97  416.03  721,971 
03/22/2024 417.75  417.75  412.19  415.66  808,164 
03/21/2024 415.61  419.26  414.09  415.71  878,823 
03/20/2024 414.51  414.51  409.02  412.11  793,314 
03/19/2024 412.51  415.70  411.10  415.20  844,417 
03/18/2024 409.25  415.50  409.25  411.38  926,245 
03/15/2024 409.18  411.64  406.97  407.69  1,894,452 
03/14/2024 414.01  414.98  407.11  408.77  1,007,523 
03/13/2024 414.46  415.92  410.39  413.20  764,165 
03/12/2024 413.00  416.11  409.02  412.45  866,850 
03/11/2024 414.00  416.71  409.52  414.47  1,242,142 
03/08/2024 412.34  416.25  410.95  413.59  807,510 
03/07/2024 415.15  418.16  410.23  410.54  922,951 
03/06/2024 414.23  418.22  410.67  411.85  1,204,971 
03/05/2024 424.87  425.49  414.04  415.44  1,113,593 
03/04/2024 432.73  433.85  422.16  424.03  1,072,927 
03/01/2024 423.20  433.67  423.00  432.76  1,091,462 
02/29/2024 429.18  429.18  420.30  420.74  1,844,619 
02/28/2024 429.60  433.49  425.71  426.97  778,845 
02/27/2024 434.13  437.00  430.52  430.92  907,635 
02/26/2024 425.70  434.26  425.70  433.48  787,655 
02/23/2024 430.00  434.47  429.07  430.11  746,936 
02/22/2024 419.85  429.81  419.85  426.78  1,031,975 
02/21/2024 421.77  424.00  414.80  419.63  906,525 
02/20/2024 420.79  425.00  416.17  420.64  1,040,374 
02/16/2024 427.04  427.04  420.97  422.20  1,176,401 
02/15/2024 419.16  427.40  418.61  426.29  1,473,593 
02/14/2024 418.38  420.45  414.26  417.88  1,133,112 
02/13/2024 417.36  419.42  412.77  416.04  1,163,878 
02/12/2024 420.24  421.30  415.28  418.53  1,340,000 
02/09/2024 425.96  425.96  419.51  422.91  1,169,486 
02/08/2024 420.28  424.48  417.14  423.06  1,380,000 
02/07/2024 416.74  426.72  416.74  419.08  1,990,000 
02/06/2024 428.76  430.99  410.80  416.13  4,500,000 
02/05/2024 424.99  430.93  421.90  428.89  1,760,000 
02/02/2024 430.00  431.29  424.31  424.68  2,181,464 
02/01/2024 434.00  435.19  431.00  433.87  1,410,000 
01/31/2024 441.57  444.07  430.12  433.38  2,740,000 
01/30/2024 430.00  448.40  429.69  446.08  3,310,000 
01/29/2024 430.85  435.82  429.40  435.82  961,440 
01/26/2024 431.03  432.19  428.14  430.17  909,630 
01/25/2024 428.06  431.35  427.06  429.96  1,150,000 
01/24/2024 436.93  437.39  424.34  427.56  1,670,000 
01/23/2024 440.01  441.57  436.31  439.70  779,570 
01/22/2024 437.64  443.82  437.64  440.11  1,410,000 
01/19/2024 433.52  435.19  429.68  435.02  2,580,000 
01/18/2024 431.59  434.88  425.41  432.98  1,330,000 
01/17/2024 437.50  439.44  432.32  433.76  1,410,000 

About Vertex Pharmaceuticals Stock history

Vertex Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vertex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vertex Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vertex Pharmaceuticals stock prices may prove useful in developing a viable investing in Vertex Pharmaceuticals
Last ReportedProjected for Next Year
Common Stock Shares Outstanding260.5 M153.1 M
Net Income Applicable To Common Shares3.8 BB

Vertex Pharmaceuticals Quarterly Net Working Capital

10.6 Billion

Vertex Pharmaceuticals Stock Technical Analysis

Vertex Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Vertex Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vertex Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Pattern Recognition Now

   

Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
All  Next Launch Module

Vertex Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Vertex Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Vertex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vertex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Vertex Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vertex Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vertex Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vertex Pharmaceuticals Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Is Vertex Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.181
Earnings Share
13.89
Revenue Per Share
38.297
Quarterly Revenue Growth
0.093
Return On Assets
0.1317
The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.